Related Experiment Videos
Human fetal tissue research: practice, prospects, and policy
1Department of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Cell Transplantation
|March 1, 1994
Summary
Human fetal tissue offers unique therapeutic potential for diseases like Parkinson's and diabetes. Ongoing research and clinical trials highlight its value, though ethical considerations require careful management.
Area of Science:
- Regenerative Medicine
- Transplantation Biology
- Medical Ethics
Background:
- Human fetal cadaver tissue has historically been vital for medical research and therapeutic development.
- Recent advancements have significantly expanded the applications of fetal tissue transplantation.
- Fetal tissue possesses unique properties making it invaluable for research and treatment.
Purpose of the Study:
- To review the current applications and future potential of human fetal tissue in medicine.
- To highlight the progress in fetal tissue transplantation for treating various human diseases.
- To address the ethical and logistical challenges associated with fetal tissue procurement and use.
Main Methods:
- Review of recent scientific literature on fetal tissue research and transplantation.
- Analysis of ongoing clinical trials utilizing fetal tissue therapies.
- Discussion of ethical considerations and regulatory frameworks.
Main Results:
- Clinical trials are underway for Parkinson's disease, diabetes mellitus, and other disorders using fetal tissue transplantation.
- Laboratory studies indicate broader future applications for treating a range of conditions.
- No satisfactory alternatives currently exist for many applications of human fetal tissue.
Conclusions:
- Human fetal tissue remains a critical resource for medical research and therapy, with significant ongoing clinical investigation.
- Unique biological characteristics of fetal tissue support its use in regenerative medicine and vaccine development.
- Addressing ethical and procurement issues through guidelines is essential for continued legitimate research and therapeutic use.